Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -166.51x is 215% below its 3-year average of -52.93x, near the low end of its 3-year range (-166.51x–-22.77x).
As of the fiscal period ended Saturday, September 30, 2023. 102.44% below its 12-month average of -82.25x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2023 (2023-09-30): -166.51x.
INTEREST COVERAGE RATIO
-166.51x
INTEREST COVERAGE RATIO AVG TTM
-82.25x
INTEREST COVERAGE RATIO AVG 3Y
-50.22x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-102.44%
CURRENT VS 3Y AVG
-231.58%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
-3855.22%
vs the sector median at left
C4 Therapeutics, Inc.
Market Cap
$329.49M
Interest Coverage Ratio
-166.51x
TTM Avg
-82.25x
3Y Avg
-50.22x
5Y Avg
N/A
Market Cap
$334.26M
Interest Coverage Ratio
-85.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$339.93M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$311.25M
Interest Coverage Ratio
N/A
TTM Avg
12.71x
3Y Avg
12.71x
5Y Avg
12.71x
Market Cap
$348.63M
Interest Coverage Ratio
-10.12x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$348.85M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$350.42M
Interest Coverage Ratio
-0.37x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.39x
Market Cap
$305.38M
Interest Coverage Ratio
-3588.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | $329.49M | -166.51x | -82.25x | -50.22x | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $334.26M | -85.95x | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $339.93M | N/A | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $318.27M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $311.25M | N/A | 12.71x | 12.71x | 12.71x |
| ClearPoint Neuro, Inc. (CLPT)vs › | $348.63M | -10.12x | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $348.85M | 3.07x | 2.31x | 3.74x | 3.74x |
| Agenus Inc. (AGEN)vs › | $350.42M | -0.37x | 0.39x | 0.39x | 0.39x |
| Standard BioTools Inc. (LAB)vs › | $305.38M | -3588.65x | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $359.16M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
Interest Coverage
-166.5x
Debt/Equity
0.23
Current Ratio
5.45
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-09-30 | -166.51x |
| 2023-06-30 | -62.61x |
| 2023-03-31 | -59.78x |
| 2022-12-31 | -63.72x |
| 2022-09-30 | -58.64x |
| 2022-06-30 | -51.28x |
| 2022-03-31 | -59.52x |
| 2021-12-31 | -28.30x |
| 2021-09-30 | -45.00x |
| 2021-06-30 | -41.49x |
| 2021-03-31 | -76.84x |
| 2020-12-31 | -22.77x |
| 2020-09-30 | -32.65x |
| 2020-06-30 | -85.50x |
